Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.53 HKD
Change Today 0.00 / 0.00%
Volume 768.0K
455 On Other Exchanges
Symbol
Exchange
Hong Kong
As of 4:01 AM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

tianda pharmaceuticals ltd (455) Snapshot

Open
$0.53
Previous Close
$0.53
Day High
$0.53
Day Low
$0.52
52 Week High
05/14/15 - $0.58
52 Week Low
01/19/15 - $0.32
Market Cap
991.2M
Average Volume 10 Days
7.1M
EPS TTM
$-0.0015
Shares Outstanding
1.9B
EX-Date
09/8/14
P/E TM
--
Dividend
$0.0024
Dividend Yield
0.45%
Current Stock Chart for TIANDA PHARMACEUTICALS LTD (455)

Related News

No related news articles were found.

tianda pharmaceuticals ltd (455) Related Businessweek News

No Related Businessweek News Found

tianda pharmaceuticals ltd (455) Details

Tianda Pharmaceuticals Limited, an investment holding company, is engaged in the research and development, production, and sale of pharmaceutical, biotechnology, and healthcare products. The company’s principal product consists of Cerebroprotein Hydrolysate Injection for craniocerebral trauma; to improve sequelae of cerebrovascular and improve deficiency of brain function; and that is conducive to those patients who lack protein or with neurasthenia. It offers cardio-cerebrovascular, pediatric, cold and respiratory system, anti-infective, and detoxification drugs, as well as complementary health care products, such as bone health, heart health, immune booster, nutritional oil, vitamin and mineral, women’s nutrition, well being, and personal care products. It operates in the People’s Republic of China, Hong Kong, and Australia. The company was formerly known as Tianda Holdings Limited and changed its name to Tianda Pharmaceuticals Limited in September 2012. Tianda Pharmaceuticals Limited is headquartered in Central, Hong Kong. Tianda Pharmaceuticals Limited is a subsidiary of Tianda Group Limited.

456 Employees
Last Reported Date: 12/19/14

tianda pharmaceuticals ltd (455) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

tianda pharmaceuticals ltd (455) Key Developments

Tianda Pharmaceuticals Limited Provides Consolidated Earnings Guidance for the Financial Year Ended 31 March 2015

Tianda Pharmaceuticals Limited provided consolidated earnings guidance for the financial year ended 31 March 2015. For the period, the company expected to record consolidated loss as compared with the consolidated profit recorded in the financial year ended 31 March 2014. Due to Yunnan Meng Sheng Pharmaceutical Co., Limited, a subsidiary of the company, took longer time than expected for its construction works for expansion of the original production line and the New GMP authentication that the New GMP Version certificate was obtained in late January 2015. As a consequence, its sales and earnings were affected and in turn led to the expected Group's consolidated loss.

Tianda Pharmaceuticals Limited Appoints SHI Shaobin as Executive Director

Tianda Pharmaceuticals Limited announced that Mr. SHI Shaobin has been appointed as an executive Director of the company with effect from 13 March 2015. Mr. SHI currently acts as the chairman of Guangzhou Electronic Commerce Network.

Tianda Pharmaceuticals Limited Announces Unaudited Consolidated Cash Flow Results for the Six Months Ended September 30, 2014

Tianda Pharmaceuticals Limited announced unaudited consolidated cash flow results for the six months ended September 30, 2014. For the six months, the company announced net cash used in operating activities was HKD 13,434,482 compared to net cash generated from operating activities of HKD 34,848,906 for the same period a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
455:HK $0.53 HKD 0.00

455 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 455.
View Industry Companies
 

Industry Analysis

455

Industry Average

Valuation 455 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 5.2x
Price/Book 1.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TIANDA PHARMACEUTICALS LTD, please visit www.tiandapharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.